GRAF JAMES A (Chief Executive Officer) purchased 23.00 shares of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $67.30. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/22/2023ACC: 0001209191-23-056524
Officer10% Owner· Chief Executive Officer
Since May 2021
+23.00
Net shares
Net buyer
$67.30
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
23.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.00
Price / share
$2.94
Trade value
$29.40
% of position
New position
11/20/2023
0.00→10.00
Common Stock
Direct
Shares
+13.00
Price / share
$2.92
Trade value
$37.90
% of position
130.0%
11/21/2023
10.00→23.00
Total
Net shares
+23.00
Net value
$67.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2023 | P · Purchase | +10.00 | $2.94 | $29.40 | New position | 0.00 | 10.00 |
| Common Stock Direct | 11/21/2023 | P · Purchase | +13.00 | $2.92 | $37.90 | 130.0% | 10.00 | 23.00 |
| Total | +23.00 | $67.30 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.44M
Total
2.44M indirect2.44M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.44M | Indirect |
| Total | 2.44M | 2.44M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported